摘要 |
The present invention features processes for preparing compounds, such as ( R )-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (Compound 1), useful for treating CFTR mediated diseases such as cystic fibrosis. |
申请人 |
VERTEX PHARMACEUTICALS INC. |
发明人 |
LEE, ELAINE, CHUNGMIN;TANOURY, GERALD, J.;HARRISON, CRISTIAN;LITTLER, BENJAMIN, JOSEPH;ROSE, PETER, JAMISON;HUGHES, ROBERT MICHAEL;JUNG, YOUNG CHUN;SIESEL, DAVID, ANDREW;BELMONT, DANIEL, T |